➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKesson
Medtronic
Express Scripts
Mallinckrodt

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Children's Fexofenadine Hydrochloride Allergy patents expire, and when can generic versions of Children's Fexofenadine Hydrochloride Allergy launch?

Children's Fexofenadine Hydrochloride Allergy is a drug marketed by P And L, Taro, Dr Reddys Labs Ltd, Aurolife Pharma Llc, Hetero Labs Ltd V, Mylan, Sun Pharm Inds, Teva, and Wockhardt Ltd. and is included in ten NDAs.

The generic ingredient in CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and two suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Children's Fexofenadine Hydrochloride Allergy

A generic version of CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.

  Start Trial

Summary for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Drug patent expirations by year for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Recent Clinical Trials for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
SanofiPhase 4

See all CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY clinical trials

Pharmacology for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY

US Patents and Regulatory Information for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
P And L CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride SUSPENSION;ORAL 203330-001 Nov 18, 2014 OTC No No   Start Trial   Start Trial   Start Trial
Mylan CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 077081-004 Jul 21, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 202039-001 Nov 19, 2014 OTC No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 091567-002 Feb 6, 2012 OTC No No   Start Trial   Start Trial   Start Trial
Taro CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride SUSPENSION;ORAL 208123-001 Nov 9, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202978-001 Jan 18, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
McKesson
McKinsey
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.